Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
XORTX Therapeutics Inc. (XRTX) had Normalized Income after Taxes of $-1.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.69M |
|
-- |
|
-- |
|
$1.69M |
|
$-1.69M |
|
$-0.00M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
|
Normalized Income after Taxes |
$-1.69M |
$-1.69M |
|
$-1.67M |
|
1.62M |
|
1.62M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$2.44M |
|
-- |
|
$3.75M |
|
$6.18M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$5.50M |
|
$2.96M |
|
$5.50M |
|
1.73M |
|
| Cash Flow Statement Financials | |
$-3.77M |
|
$-0.15M |
|
$4.05M |
|
$0.86M |
|
$0.99M |
|
$0.13M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.71% |
|
-57.17% |
|
-27.34% |
|
-30.71% |
|
$3.18 |
|
$-2.33 |
|
$-2.33 |
|